Diabetes Kongress 2020
zur Liste
Sylvia Sadzio
Lilly Deutschland GmbH Germany
  • Vortrag Preferences for profiles of Dulaglutide and Semaglutide, two injectable GLP-1 receptor agonists, among injection-naïve patients with type 2 diabetes in Germany Speaker
    Datum: 21.05.2020 , Zeit: 16:56 | Thema: Poster
    Details